Cholangiocarcinoma Global Market Report 2025

Cholangiocarcinoma Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cholangiocarcinoma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for cholangiocarcinoma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cholangiocarcinoma market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Cancer: Intrahepatic Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma

2) By Product: Capecitabine; 5-Fluorouracil; Oxaliplatin; Gemcitabine; Cisplatin

3) By Therapy: Targeted Drug Therapy; Chemotherapy; Immunotherapy

4) By Route Of Administration: Oral; Subcutaneous; Intravenous

5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; E-Commerce

Subsegments:

1) By Intrahepatic Cholangiocarcinoma: Peripheral Intrahepatic Cholangiocarcinoma; Mass-Forming Intrahepatic Cholangiocarcinoma

2) By Extrahepatic Cholangiocarcinoma: Perihilar Cholangiocarcinoma; Distal Cholangiocarcinoma

Companies Mentioned: F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company; AstraZeneca PLC

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Cholangiocarcinoma Market Characteristics
3. Cholangiocarcinoma Market Trends And Strategies
4. Cholangiocarcinoma Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Cholangiocarcinoma Growth Analysis And Strategic Analysis Framework
5.1. Global Cholangiocarcinoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cholangiocarcinoma Market Growth Rate Analysis
5.4. Global Cholangiocarcinoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cholangiocarcinoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cholangiocarcinoma Total Addressable Market (TAM)
6. Cholangiocarcinoma Market Segmentation
6.1. Global Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
6.2. Global Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Capecitabine
5-Fluorouracil
Oxaliplatin
Gemcitabine
Cisplatin
6.3. Global Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Drug Therapy
Chemotherapy
Immunotherapy
6.4. Global Cholangiocarcinoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Subcutaneous
Intravenous
6.5. Global Cholangiocarcinoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
E-Commerce
6.6. Global Cholangiocarcinoma Market, Sub-Segmentation Of Intrahepatic Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peripheral Intrahepatic Cholangiocarcinoma
Mass-Forming Intrahepatic Cholangiocarcinoma
6.7. Global Cholangiocarcinoma Market, Sub-Segmentation Of Extrahepatic Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Perihilar Cholangiocarcinoma
Distal Cholangiocarcinoma
7. Cholangiocarcinoma Market Regional And Country Analysis
7.1. Global Cholangiocarcinoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cholangiocarcinoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cholangiocarcinoma Market
8.1. Asia-Pacific Cholangiocarcinoma Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cholangiocarcinoma Market
9.1. China Cholangiocarcinoma Market Overview
9.2. China Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cholangiocarcinoma Market
10.1. India Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cholangiocarcinoma Market
11.1. Japan Cholangiocarcinoma Market Overview
11.2. Japan Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cholangiocarcinoma Market
12.1. Australia Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cholangiocarcinoma Market
13.1. Indonesia Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cholangiocarcinoma Market
14.1. South Korea Cholangiocarcinoma Market Overview
14.2. South Korea Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cholangiocarcinoma Market
15.1. Western Europe Cholangiocarcinoma Market Overview
15.2. Western Europe Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cholangiocarcinoma Market
16.1. UK Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cholangiocarcinoma Market
17.1. Germany Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cholangiocarcinoma Market
18.1. France Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cholangiocarcinoma Market
19.1. Italy Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cholangiocarcinoma Market
20.1. Spain Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cholangiocarcinoma Market
21.1. Eastern Europe Cholangiocarcinoma Market Overview
21.2. Eastern Europe Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cholangiocarcinoma Market
22.1. Russia Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cholangiocarcinoma Market
23.1. North America Cholangiocarcinoma Market Overview
23.2. North America Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cholangiocarcinoma Market
24.1. USA Cholangiocarcinoma Market Overview
24.2. USA Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cholangiocarcinoma Market
25.1. Canada Cholangiocarcinoma Market Overview
25.2. Canada Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cholangiocarcinoma Market
26.1. South America Cholangiocarcinoma Market Overview
26.2. South America Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cholangiocarcinoma Market
27.1. Brazil Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cholangiocarcinoma Market
28.1. Middle East Cholangiocarcinoma Market Overview
28.2. Middle East Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cholangiocarcinoma Market
29.1. Africa Cholangiocarcinoma Market Overview
29.2. Africa Cholangiocarcinoma Market, Segmentation By Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cholangiocarcinoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cholangiocarcinoma Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cholangiocarcinoma Market Competitive Landscape And Company Profiles
30.1. Cholangiocarcinoma Market Competitive Landscape
30.2. Cholangiocarcinoma Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
31. Cholangiocarcinoma Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. Takeda Pharmaceutical Company Limited
31.3. Eli Lilly and Company
31.4. Boston Scientific Corporation
31.5. Servier Laboratories
31.6. Incyte Corporation
31.7. Exelixis Inc.
31.8. Hutchison China MediTech Limited
31.9. Zymeworks Inc.
31.10. Agios Pharmaceuticals Inc.
31.11. RenovoRx Inc.
31.12. Specialised Therapeutics Pty Ltd
31.13. Ascletis Pharma Inc.
31.14. Tiziana Life Sciences Ltd.
31.15. Taiho Pharmaceutical Co. Ltd.
32. Global Cholangiocarcinoma Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cholangiocarcinoma Market
34. Recent Developments In The Cholangiocarcinoma Market
35. Cholangiocarcinoma Market High Potential Countries, Segments and Strategies
35.1 Cholangiocarcinoma Market In 2029 - Countries Offering Most New Opportunities
35.2 Cholangiocarcinoma Market In 2029 - Segments Offering Most New Opportunities
35.3 Cholangiocarcinoma Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings